Comparing two sample pooling strategies for SARS‐CoV‐2 RNA detection for efficient screening of COVID‐19
Open Access
- 27 October 2020
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (5), 2805-2809
- https://doi.org/10.1002/jmv.26632
Abstract
The emerging pandemic of coronavirus disease 2019 (COVID‐19) has affected over 200 countries and resulted in a shortage of diagnostic resources globally. Rapid diagnosis of COVID‐19 is vital to control the spreading of the disease, which however is challenged by limited detection capacity and low detection efficiency in many parts of the world. The pooling test may offer an economical and effective approach to increase virus testing capacity of medical laboratories without requiring more laboratory resources such as laboratory workers, testing reagents and equipment. In this study, the sample pools of 6 and 10 were detected by a real‐time Reverse Transcription‐Polymerase Chain Reaction (RT‐PCR) assay targeting ORF1ab and N genes of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Each pool consisted of 5 or 9 negative SARS‐CoV‐2 samples and 1 positive counterpart with varying viral loads. Two different strategies of sample pooling were investigated and the results were compared comprehensively. One approach was to pool viral transport medium (VTM) of the samples in the laboratory, and the other was to pool swab samples during collection process. For swab pooling strategy, qualitative results of SARS‐CoV‐2 RNA, specific tests of ORF1ab and N genes, remained stable over the different pool sizes. Together, this study demonstrates that the swab pooling strategy may serve as an effective and economical approach for screening SARS‐CoV‐2 infections in large populations, especially in countries and regions where medical resources are limited during the pandemic and may thus be potential for clinical laboratory applications.Keywords
This publication has 7 references indexed in Scilit:
- Pooling of samples for testing for SARS-CoV-2 in asymptomatic peopleThe Lancet Infectious Diseases, 2020
- Group Testing for Severe Acute Respiratory Syndrome– Coronavirus 2 to Enable Rapid Scale-up of Testing and Real-Time Surveillance of IncidenceThe Journal of Infectious Diseases, 2020
- Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detectionClinical Microbiology & Infection, 2020
- Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing ResourcesAmerican Journal of Clinical Pathology, 2020
- Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2JAMA, 2020
- High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in JapanJournal of Virological Methods, 2003
- Mini‐pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary resultsTransfusion, 1998